{"brief_title": "Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)", "brief_summary": "To determine the efficacy and safety of an investigational compound (MK0966) for the prevention of prostate cancer.", "detailed_description": "The duration of treatment is 6 years.", "condition": "Prostate Cancer", "intervention_type": "Drug", "intervention_name": "Comparator: placebo (unspecified)", "other_name": "MK0966", "criteria": "Regular PSA testing and study biopsies required.", "gender": "Male", "minimum_age": "50 Years", "maximum_age": "75 Years", "healthy_volunteers": "No", "id": "NCT00060476.xml"}